Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Gemini Therapeutics, Inc. stock logo
GMTX
Gemini Therapeutics
$27.00
+0.1%
$53.77
$1.16
$14.10
$1.17B-0.12189,291 shs554,062 shs
Inhibrx, Inc. stock logo
INBX
Inhibrx
$34.38
+0.7%
$35.72
$14.31
$39.79
$1.63B2.91678,139 shs207,893 shs
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
$24.74
-3.2%
$25.05
$13.34
$28.35
$1.90B0.43635,677 shs358,710 shs
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
$26.18
+0.8%
$27.03
$25.00
$34.53
$2.35B1.061.02 million shs471,381 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Gemini Therapeutics, Inc. stock logo
GMTX
Gemini Therapeutics
-5.89%-11.53%-55.45%-59.07%-13.88%
Inhibrx, Inc. stock logo
INBX
Inhibrx
+0.09%-1.39%-2.18%-5.85%+64.09%
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
+5.53%+2.90%-1.12%+30.39%+59.41%
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
+0.23%+1.33%-4.73%-12.94%-4.84%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Gemini Therapeutics, Inc. stock logo
GMTX
Gemini Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Inhibrx, Inc. stock logo
INBX
Inhibrx
2.1061 of 5 stars
1.02.00.04.62.13.30.0
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
3.6502 of 5 stars
2.01.00.03.91.12.53.1
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
4.5239 of 5 stars
3.15.03.31.71.11.71.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Gemini Therapeutics, Inc. stock logo
GMTX
Gemini Therapeutics
N/AN/AN/AN/A
Inhibrx, Inc. stock logo
INBX
Inhibrx
2.00
Hold$27.00-21.47% Downside
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
2.00
Hold$23.29-5.88% Downside
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
2.29
Hold$33.1126.47% Upside

Current Analyst Ratings

Latest OMI, PDCO, INBX, and GMTX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/10/2024
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$24.00 ➝ $28.00
3/6/2024
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$31.00 ➝ $30.00
2/29/2024
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral$34.00 ➝ $28.00
2/26/2024
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
2/26/2024
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Perform$24.00
2/26/2024
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
2/26/2024
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$36.00
2/21/2024
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$23.00 ➝ $24.00
2/21/2024
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$21.00 ➝ $23.00
1/29/2024
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$28.00 ➝ $26.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Gemini Therapeutics, Inc. stock logo
GMTX
Gemini Therapeutics
N/AN/AN/AN/A$2.89 per shareN/A
Inhibrx, Inc. stock logo
INBX
Inhibrx
$1.80M905.15N/AN/A$0.92 per share37.37
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
$10.33B0.18$5.24 per share4.72$12.08 per share2.05
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
$6.47B0.36$3.31 per share7.91$11.45 per share2.29

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Gemini Therapeutics, Inc. stock logo
GMTX
Gemini Therapeutics
-$71.87M-$1.00N/AN/AN/AN/A-38.78%-35.88%N/A
Inhibrx, Inc. stock logo
INBX
Inhibrx
-$241.36M-$5.03N/AN/A-13,408.95%-590.78%-84.13%5/13/2024 (Estimated)
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
-$41.30M-$0.54N/A12.620.77-0.40%11.62%2.03%5/3/2024 (Confirmed)
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
$207.56M$2.0312.9010.561.362.95%20.98%7.70%6/19/2024 (Estimated)

Latest OMI, PDCO, INBX, and GMTX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/3/2024N/A
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
$0.17N/A-$0.17N/AN/AN/A  
2/28/2024Q4 2023
Inhibrx, Inc. stock logo
INBX
Inhibrx
-$1.07-$1.73-$0.66-$1.73$0.10 million$1.63 million
2/28/2024Q3 2024
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
$0.60$0.59-$0.01$0.66$1.63 billion$1.62 billion      
2/20/202412/31/2023
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
$0.66$0.69+$0.03$1.15$2.67 billion$2.66 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Gemini Therapeutics, Inc. stock logo
GMTX
Gemini Therapeutics
N/AN/AN/AN/AN/A
Inhibrx, Inc. stock logo
INBX
Inhibrx
N/AN/AN/AN/AN/A
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
N/AN/AN/AN/AN/A
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
$1.043.97%N/A51.23%N/A

Latest OMI, PDCO, INBX, and GMTX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/11/2024
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
Quarterly$0.263.86%4/18/20244/19/20245/3/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Gemini Therapeutics, Inc. stock logo
GMTX
Gemini Therapeutics
N/A
71.49
71.49
Inhibrx, Inc. stock logo
INBX
Inhibrx
4.78
5.24
5.25
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
2.05
1.11
0.52
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
0.46
1.43
0.72

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Gemini Therapeutics, Inc. stock logo
GMTX
Gemini Therapeutics
75.42%
Inhibrx, Inc. stock logo
INBX
Inhibrx
82.46%
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
98.04%
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
85.43%

Insider Ownership

CompanyInsider Ownership
Gemini Therapeutics, Inc. stock logo
GMTX
Gemini Therapeutics
12.90%
Inhibrx, Inc. stock logo
INBX
Inhibrx
25.80%
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
2.62%
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
1.50%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Gemini Therapeutics, Inc. stock logo
GMTX
Gemini Therapeutics
3143.33 million37.74 millionNot Optionable
Inhibrx, Inc. stock logo
INBX
Inhibrx
16647.39 million35.17 millionOptionable
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
13,70076.60 million74.59 millionOptionable
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
7,60089.59 million88.25 millionOptionable

OMI, PDCO, INBX, and GMTX Headlines

SourceHeadline
Winston-Salem police break up crowd on Patterson Avenue gathered during a fightWinston-Salem police break up crowd on Patterson Avenue gathered during a fight
journalnow.com - April 24 at 2:40 PM
Duality Advisers LP Buys New Position in Patterson Companies, Inc. (NASDAQ:PDCO)Duality Advisers LP Buys New Position in Patterson Companies, Inc. (NASDAQ:PDCO)
marketbeat.com - April 23 at 7:52 AM
Dozens take the Plunge for Patterson to benefit research for rare skin disorderDozens take the 'Plunge for Patterson' to benefit research for rare skin disorder
msn.com - April 22 at 8:34 PM
Mark Patterson reopens world’s largest wool processing facilityMark Patterson reopens world’s largest wool processing facility
devdiscourse.com - April 22 at 9:22 AM
Victoria’s alleged mushroom murders: who are Erin Patterson and the other key figures?Victoria’s alleged mushroom murders: who are Erin Patterson and the other key figures?
theguardian.com - April 22 at 9:22 AM
Earth Day 2024: NY dairy farms are committed to protecting the planet (Guest Opinion by Jon Patterson)Earth Day 2024: NY dairy farms are committed to protecting the planet (Guest Opinion by Jon Patterson)
syracuse.com - April 22 at 9:22 AM
Erin Patterson returns to courtErin Patterson returns to court
9news.com.au - April 22 at 12:24 AM
Erin Patterson: Murder accused mushroom cook flags desire to have case heard near her local communityErin Patterson: Murder accused mushroom cook flags desire to have case heard near her local community
thechronicle.com.au - April 22 at 12:24 AM
Mark Patterson reopens world’s largest wool scouring facilityMark Patterson reopens world’s largest wool scouring facility
voxy.co.nz - April 22 at 12:24 AM
Mushroom meal murder: accused Erin Patterson faces Victorian courtMushroom meal murder: accused Erin Patterson faces Victorian court
msn.com - April 22 at 12:24 AM
Deadly mushroom dinner: Erin Patterson appears in court accused of triple murder in AustraliaDeadly mushroom dinner: Erin Patterson appears in court accused of triple murder in Australia
msn.com - April 22 at 12:24 AM
Triple-accused murderer Erin Patterson, 49, returns to court in alleged mushroom poisoning case for first time in five monthsTriple-accused murderer Erin Patterson, 49, returns to court in alleged mushroom poisoning case for first time in five months
skynews.com.au - April 22 at 12:24 AM
Hussman Strategic Advisors Inc. Grows Position in Patterson Companies, Inc. (NASDAQ:PDCO)Hussman Strategic Advisors Inc. Grows Position in Patterson Companies, Inc. (NASDAQ:PDCO)
marketbeat.com - April 21 at 3:10 PM
Victoria’s alleged mushroom murders case: Erin Patterson set to face court on MondayVictoria’s alleged mushroom murders case: Erin Patterson set to face court on Monday
theguardian.com - April 21 at 2:24 PM
Patterson Ave. closed after crash downs power lines in Winston-SalemPatterson Ave. closed after crash downs power lines in Winston-Salem
msn.com - April 21 at 2:24 PM
Arkansas O-lineman Patterson plans to enter transfer portalArkansas O-lineman Patterson plans to enter transfer portal
arkansasonline.com - April 21 at 7:57 AM
David Patterson breached Procurement Act when he was Public Infrastructure MinisterDavid Patterson breached Procurement Act when he was Public Infrastructure Minister
guyanachronicle.com - April 21 at 7:57 AM
Roanoke Fire controls house fire on Patterson Ave SWRoanoke Fire controls house fire on Patterson Ave SW
msn.com - April 21 at 1:40 AM
Two NH residents recommend picking up the phone if James Patterson callsTwo NH residents recommend picking up the phone if James Patterson calls
unionleader.com - April 19 at 8:27 PM
Nathan Patterson: Scotland & Everton right-back out for rest of seasonNathan Patterson: Scotland & Everton right-back out for rest of season
skysports.com - April 19 at 3:27 PM
Soccer-Blow for Everton as defender Patterson out for the seasonSoccer-Blow for Everton as defender Patterson out for the season
thestar.com.my - April 19 at 3:27 PM
Scotland At UEFA Euro 2024: Operation Puts Patterson’s European Championship Hopes In DoubtScotland At UEFA Euro 2024: Operation Puts Patterson’s European Championship Hopes In Doubt
outlookindia.com - April 19 at 3:27 PM
Patterson surgery, Everton could have Branthwaite, Calvert-Lewin & Gana availablePatterson surgery, Everton could have Branthwaite, Calvert-Lewin & Gana available
royalbluemersey.sbnation.com - April 19 at 3:27 PM
Brooks Patterson’s daughter quits race for Oakland County executiveBrooks Patterson’s daughter quits race for Oakland County executive
msn.com - April 19 at 3:27 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Gemini Therapeutics logo

Gemini Therapeutics

NASDAQ:GMTX
Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients. The company also develops GEM307 for treatment of systemic diseases. Gemini Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts.
Inhibrx logo

Inhibrx

NASDAQ:INBX
Inhibrx, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent therapeutic candidate targeting death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, colorectal cancer, ewing sarcoma, and pancreatic adenocarcinoma; and INBRX-101, an alpha-1 antitrypsin (AAT)-Fc fusion protein therapeutic candidate, which is in Phase 1 clinical trials for use in the treatment of patients with AAT deficiency. It also develops INBRX-106, a hexavalent agonist of OX40 for a range of oncology indications. The company has license and collaboration agreements with 2seventy bio, Inc. and Bristol-Myers Squibb Company. Inhibrx, Inc. was incorporated in 2009 and is headquartered in La Jolla, California.
Owens & Minor logo

Owens & Minor

NYSE:OMI
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment supplies a range of other home medical equipment, patient care products, including ostomy, wound care, urology, incontinence and other products and services. It serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is headquartered in Richmond, Virginia.
Patterson Companies logo

Patterson Companies

NASDAQ:PDCO
Patterson Companies, Inc. engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems. It also provides a range of related services comprising software and design services, maintenance and repair, and equipment financing. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional's, consumable supplies, equipment, and software, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.